Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

SELL
$0.81 - $1.34 $25,323 - $41,893
-31,264 Closed
0 $0
Q2 2020

Aug 07, 2020

BUY
$8.53 - $25.64 $65,715 - $197,530
7,704 Added 32.7%
31,264 $653,000
Q1 2020

May 05, 2020

BUY
$7.98 - $16.32 $30,403 - $62,179
3,810 Added 19.29%
23,560 $230,000
Q2 2019

Aug 05, 2019

BUY
$5.1 - $11.89 $19,737 - $46,014
3,870 Added 24.37%
19,750 $235,000
Q2 2018

Aug 06, 2018

BUY
$5.3 - $6.9 $84,164 - $109,572
15,880 New
15,880 $84,000

Others Institutions Holding ADVM

About Adverum Biotechnologies, Inc.


  • Ticker ADVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,333,600
  • Market Cap $471M
  • Description
  • Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...
More about ADVM
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.